Platelet activating factor

Platelet activating factor is a lipid of Glycerophospholipids (GP) class. Platelet activating factor is associated with abnormalities such as Atherosclerosis, Acute cholecystitis without calculus, Cholecystitis, Colitis and Cholecystitis, Acute. The involved functions are known as Cell Survival, Metabolic Inhibition, lipid oxidation, Apoptosis and Oxidation. Platelet activating factor often locates in soluble, Cellular Membrane, Smooth muscle (tissue), Intima and Tissue specimen. The associated genes with Platelet activating factor are apolipoprotein A-I Milano, Homologous Gene, TSPO gene, HBEGF gene and SLC33A1 gene. The related lipids are Hydroxycholesterols, Liposomes, 25-hydroxycholesterol, Lysophosphatidylcholines and Lipopolysaccharides. The related experimental models are Knock-out, Mouse Model and Transgenic Model.

Cross Reference

Introduction

To understand associated biological information of Platelet activating factor, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Platelet activating factor?

Platelet activating factor is suspected in Ischemia, Pleurisy, Atherosclerosis, Inflammatory disorder, Retinal Diseases, Diabetes and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Platelet activating factor

MeSH term MeSH ID Detail
Adenocarcinoma D000230 166 associated lipids
Agranulocytosis D000380 7 associated lipids
Albuminuria D000419 18 associated lipids
Alzheimer Disease D000544 76 associated lipids
Amnesia D000647 12 associated lipids
Anaphylaxis D000707 35 associated lipids
Anemia, Sickle Cell D000755 34 associated lipids
Angina Pectoris D000787 27 associated lipids
Angina, Unstable D000789 14 associated lipids
Hypoxia D000860 23 associated lipids
Anthrax D000881 1 associated lipids
Arenaviridae Infections D001117 1 associated lipids
Arrhythmias, Cardiac D001145 42 associated lipids
Arterial Occlusive Diseases D001157 12 associated lipids
Arteriosclerosis D001161 86 associated lipids
Arteriosclerosis Obliterans D001162 8 associated lipids
Arthritis D001168 41 associated lipids
Arthritis, Experimental D001169 24 associated lipids
Arthus Reaction D001183 8 associated lipids
Ascites D001201 25 associated lipids
Per page 10 20 50 100 | Total 288

PubChem Associated disorders and diseases

What pathways are associated with Platelet activating factor

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Platelet activating factor?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Platelet activating factor?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Platelet activating factor?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with Platelet activating factor?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Platelet activating factor?

Knock-out

Knock-out are used in the study 'A cardioprotective role for platelet-activating factor through NOS-dependent S-nitrosylation.' (Leary PJ et al., 2008).

Mouse Model

Mouse Model are used in the study 'A regulatory role of LPCAT1 in the synthesis of inflammatory lipids, PAF and LPC, in the retina of diabetic mice.' (Cheng L et al., 2009).

Transgenic Model

Transgenic Model are used in the study 'Heterogeneity in the sn-1 carbon chain of platelet-activating factor glycerophospholipids determines pro- or anti-apoptotic signaling in primary neurons.' (Ryan SD et al., 2008).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with Platelet activating factor

Download all related citations
Per page 10 20 50 100 | Total 8526
Authors Title Published Journal PubMed Link
Kawasaki T and Snyder F Synthesis of a novel acetylated neutral lipid related to platelet-activating factor by acyl-CoA:1-O-alkyl-2-acetyl-sn-glycerol acyltransferase in HL-60 cells. 1988 J. Biol. Chem. pmid:3422635
Michel L et al. Inhibitory effect of oral cetirizine on in vivo antigen-induced histamine and PAF-acether release and eosinophil recruitment in human skin. 1988 J. Allergy Clin. Immunol. pmid:2899102
Michel L et al. Release of PAF-acether and precursors during allergic cutaneous reactions. 1988 Lancet pmid:2899817
Bourdillat B et al. Hispidulin, a natural flavone, inhibits human platelet aggregation by increasing cAMP levels. 1988 Eur. J. Pharmacol. pmid:2836213
Toyofuku T et al. Pulmonary vascular response to platelet-activating factor in conscious sheep. 1988 Am. J. Physiol. pmid:3414811
Yamada K et al. Parallel inhibition of platelet-activating factor-induced protein phosphorylation and serotonin release by K-252a, a new inhibitor of protein kinases, in rabbit platelets. 1988 Biochem. Pharmacol. pmid:3128296
Fernandez-Gallardo S et al. Biosynthesis of platelet-activating factor in glandular gastric mucosa. Evidence for the involvement of the 'de novo' pathway and modulation by fatty acids. 1988 Biochem. J. pmid:2848496
Slapke J et al. [Test hierarchy for the development of new drug action principles with the action site in phospholipid metabolism for bronchial asthma and pulmonary hypertension]. 1988 Prax Klin Pneumol pmid:3140230
Wang J et al. The effects of endotoxin on platelet-activating factor synthesis in cultured rat glomerular mesangial cells. 1988 Biochim. Biophys. Acta pmid:3370222
Grue-Sørensen G et al. Derivatives of 2-methylenepropane-1,3-diol as new antagonists of platelet activating factor. 1988 J. Med. Chem. pmid:3373485
Pirotzky E et al. Protection of platelet-activating factor-induced acute renal failure by BN 52021. 1988 Br J Exp Pathol pmid:3377967
Myers AK et al. Antagonism of PAF-induced death in mice. 1988 Prostaglandins pmid:3131837
Casals-Stenzel J and Heuer H Pharmacology of PAF antagonists. 1988 Prog Biochem Pharmacol pmid:3043436
Rola-Pleszczynski M PAF in cellular immunology. 1988 Prog Biochem Pharmacol pmid:3043437
Baggiolini M et al. Effects of PAF on neutrophils and mononuclear phagocytes. 1988 Prog Biochem Pharmacol pmid:3043438
Nogami M et al. [Effects of a PAF antagonist CV-3988 on the acute gastric erosions of rats by water-immersion stress]. 1988 Nihon Shokakibyo Gakkai Zasshi pmid:3404759
Biologically active ether lipids. 1988 Prog Biochem Pharmacol pmid:3405995
Taira M et al. Lack of involvement of leukotriene and platelet activating factor in passive cutaneous anaphylaxis in rats. 1988 Agents Actions pmid:3407549
Mollinedo F et al. Intracellular localization of platelet-activating factor synthesis in human neutrophils. 1988 Biochem. Biophys. Res. Commun. pmid:3408495
Ohmori K et al. Antiinflammatory and antiallergic effects of a novel metabolite of Nocardiopsis sp. as a potent protein kinase C inhibitor from microbial origin. 1988 Arzneimittelforschung pmid:2972291
Masugi F et al. Platelet-activating factor and anti-platelet-aggregating factor in acute reduction of blood pressure following percutaneous transluminal renal angioplasty in patients with renovascular hypertension. 1988 J Hum Hypertens pmid:2977405
Bussolino F et al. Platelet activating factor induces dopamine release in PC-12 cell line. 1988 Am. J. Physiol. pmid:3177629
Hill CE et al. Location of platelet activating factor binding in rat liver. 1988 Biochem. J. pmid:3178735
Crouch MF and Lapetina EG Spacial isolation of protein kinase C activation in thrombin stimulated human platelets. 1988 Biochem. Biophys. Res. Commun. pmid:3178827
Andersson M and Pipkorn U The effect of platelet activating factor on nasal hypersensitivity. 1988 Eur. J. Clin. Pharmacol. pmid:3181276
Kumar R et al. Occurrence of platelet-activating factor in rabbit spermatozoa. 1988 Arch. Biochem. Biophys. pmid:3341753
Huo YN et al. A preferential inhibition by Zn2+ on platelet activating factor- and thrombin-induced serotonin secretion from washed rabbit platelets. 1988 Arch. Biochem. Biophys. pmid:3341767
Whatley RE et al. The regulation of synthesis of platelet-activating factor by endothelial cells. 1988 Chest pmid:3342689
Ukena D et al. Radioligand binding of antagonists of platelet-activating factor to intact human platelets. 1988 FEBS Lett. pmid:3342883
Touvay C et al. Role of platelet-activating factor (PAF) in the bronchopulmonary alterations and beta-adrenoceptor function induced by endotoxin. 1988 Biochem. Biophys. Res. Commun. pmid:2835036
17th annual UCLA symposium. Abstracts: Cell activation and signal initiation: receptor and phospholipase control of inositol phosphate, PAF and eicosanoid production. 1988 J. Cell. Biochem. Suppl. pmid:2835556
Ostermann G et al. Structure-activity relationships of synthetic analogues of platelet-activating factor. 1988 Biomed. Biochim. Acta pmid:3248110
Droy-Lefaix MT et al. The amplificative role of PAF-acether in the oxidative stress following reperfusion of ischemic stomach. 1988 Basic Life Sci. pmid:3250539
Paulson SK and Nicholson NS A radioreceptor binding assay for measurement of platelet-activating factor synthesis by human neutrophils. 1988 J. Immunol. Methods pmid:2837517
Stahl GL et al. Role of platelet activating factor in propagation of cardiac damage during myocardial ischemia. 1988 J. Pharmacol. Exp. Ther. pmid:3252036
Williams WR et al. Plates and anti-asthma drugs. 1988 Pneumonol Pol pmid:3254508
Ng DS and Wong K Specific binding of platelet-activating factor (PAF) by human peripheral blood mononuclear leukocytes. 1988 Biochem. Biophys. Res. Commun. pmid:2843182
Browne PC et al. Kinetics of the formation of thrombin-thrombospondin complexes: involvement of a 77-kDa intermediate. 1988 Arch. Biochem. Biophys. pmid:2844122
Miller MJ et al. SOD prevents damage and attenuates eicosanoid release in a rabbit model of necrotizing enterocolitis. 1988 Am. J. Physiol. pmid:2847541
Schindler PW et al. Fluorophore-labeled ether lipids: substrates for enzymes of the platelet-activating factor cycle in peritoneal polymorphonuclear leukocytes. 1988 Anal. Biochem. pmid:3239750
Silva PM et al. Adrenalectomy exacerbates paw edema without interfering with desensitization induced by PAF-acether in rats. 1988 Braz. J. Med. Biol. Res. pmid:3240383
Fichelle J et al. Bronchospasmolytic effects of RU 42173. 1988 Fundam Clin Pharmacol pmid:3240917
Misawa M and Takata T [Effects of platelet activating factor on the bronchial musculature and vasculature in dogs]. 1988 Nihon Kyobu Shikkan Gakkai Zasshi pmid:3241511
Perico N et al. Effect of platelet-activating factor and its specific receptor antagonist on glomerular permeability to proteins in isolated perfused rat kidney. 1988 Lab. Invest. pmid:3123798
Aratani H et al. Effect of etizolam (Depas) on production of superoxide anion by platelet-activating factor and N-formyl-methionyl-leucyl-phenylalanine-stimulated guinea pig polymorphonuclear leukocytes. 1988 Jpn. J. Pharmacol. pmid:2848961
Robertson DN et al. The effect of platelet-activating factor on histamine and muscarinic receptor function in guinea pig airways. 1988 Am. Rev. Respir. Dis. pmid:2849329
Stewart AG and Dusting GJ Characterization of receptors for platelet-activating factor on platelets, polymorphonuclear leukocytes and macrophages. 1988 Br. J. Pharmacol. pmid:2850058
Korth R et al. Comparison of three paf-acether receptor antagonist ginkgolides. 1988 Eur. J. Pharmacol. pmid:2850196
Lakin KM et al. [Action of calcium antagonists on thrombocyte aggregation]. 1987 Sep-Oct Farmakol Toksikol pmid:2826225
Berdel WE et al. Lack of correlation between cytotoxicity of agonists and antagonists of platelet activating factor [paf-acether] in neoplastic cells and modulation of [3H]-paf-acether binding to platelets from humans in vitro. 1987 Nov-Dec Anticancer Res. pmid:3442414
Fiedler VB et al. Comparison of cardiac and hemodynamic effects of platelet-activating factor-acether and leukotriene D4 in anesthetized dogs. 1987 Mar-Apr Basic Res. Cardiol. pmid:3606544
Arnoux B et al. Antigenic release of paf-acether and beta-glucuronidase from alveolar macrophages of asthmatics. 1987 Mar-Apr Bull Eur Physiopathol Respir pmid:3607326
Lurie A et al. Exercise- and allergen-induced asthma do not change the production of Paf-acether by neutrophils and platelets. 1987 Jul-Aug Bull Eur Physiopathol Respir pmid:3690021
Auriault C et al. The effector function of platelets is induced and regulated by T lymphocytes. 1987 Jul-Aug Ann. Inst. Pasteur Immunol. pmid:3118905
Liu BN [Neoplastic membrane-toxic activity as one of the pathogenetic factors in blood cell and tumor growth changes]. 1987 Jan-Feb Patol Fiziol Eksp Ter pmid:3550649
Ramesha CS et al. Identification and quantitation of PAF from psoriatic scales. 1987 Agents Actions pmid:3687590
Friedlander G et al. Renal effects of platelet-activating factor in the rat. 1987 Agents Actions pmid:3687594
Lagente V et al. Interference of the PAF-acether antagonist BN 52021 with passive anaphylaxis in the guinea-pig. 1987 Prostaglandins pmid:2438723
Pritchard PH The degradation of platelet-activating factor by high-density lipoprotein in rat plasma. Effect of ethynyloestradiol administration. 1987 Biochem. J. pmid:3689334
Sugiyama T et al. A novel platelet aggregating factor found in a patient with defective collagen-induced platelet aggregation and autoimmune thrombocytopenia. 1987 Blood pmid:3580576
Agrawal DK and Townley RG Effect of platelet-activating factor on beta-adrenoceptors in human lung. 1987 Biochem. Biophys. Res. Commun. pmid:3030311
Hébert RL et al. Hemodynamic effects of PAF-acether on the dog kidney. 1987 Prostaglandins Leukot Med pmid:3033688
Barrio V et al. Atrial natriuretic peptide inhibits glomerular contraction induced by angiotensin II and platelet activating factor. 1987 Eur. J. Pharmacol. pmid:2952517
Camussi G et al. Receptor antagonist of platelet activating factor inhibits inflammatory injury induced by in situ formation of immune complexes in renal glomeruli and in the skin. 1987 J. Lab. Clin. Med. pmid:2955066
Patterson R et al. Evaluation of the effect of a platelet activating factor antagonist on platelet activating factor and Ascaris antigen-induced airway responses in rhesus monkeys. 1987 J. Lab. Clin. Med. pmid:3668360
Stewart AG and Piper PJ Actions of platelet-activating factor in the coronary circulation of the guinea pig in vitro. 1987 Prog. Clin. Biol. Res. pmid:3671383
Abstracts of the meeting: The role of platelet-activating factors in the immune response. Paris, France, June 25 and 26, 1987. 1987 Prostaglandins pmid:3671731
Bourgain RH et al. Arterial obstruction induced by PAF-acether (1-O-alkyl-sn-glycero-3-phosphocholine). 1987 Adv. Exp. Med. Biol. pmid:3673721
Myers AK and Bader TJ Role of adrenal steroids in the recovery from platelet activating factor challenge. 1987 Circ. Shock pmid:3677334
Mangold HK et al. Biologically active lipids. Semi-synthesis of 3H-labeled ether glycerophospholipids and ether glyceroglycolipids from ratfish liver oil. 1987 FEBS Lett. pmid:3609315
Caffrey E et al. Aggregation responses to platelet-activating factor in normal subjects. 1987 Haemostasis pmid:3609916
Baer PG and Cagen LM Platelet activating factor vasoconstriction of dog kidney. Inhibition by alprazolam. 1987 Hypertension pmid:3818022
Bittman R et al. Synthesis and biochemical studies of analogs of platelet-activating factor bearing a methyl group at C2 of the glycerol backbone. 1987 J. Lipid Res. pmid:3611974
Terashita Z et al. CV-6209, a highly potent antagonist of platelet activating factor in vitro and in vivo. 1987 J. Pharmacol. Exp. Ther. pmid:3612533
Bruijnzeel PL et al. Platelet-activating factor induces leukotriene C4 synthesis by purified human eosinophils. 1987 Prostaglandins pmid:3118415
Sha'afi RI and Molski TF Signalling for increased cytoskeletal actin in neutrophils. 1987 Biochem. Biophys. Res. Commun. pmid:3036146
Taylor RR et al. Whole blood platelet aggregation is not affected by cigarette smoking but is sex-related. 1987 Clin. Exp. Pharmacol. Physiol. pmid:3440324
Shimazaki N et al. Diketopiperazines as a new class of platelet-activating factor inhibitors. 1987 J. Med. Chem. pmid:3656347
Ruan CG et al. Studies on monoclonal antibodies against human platelets--a monoclonal antibody to human platelet glycoprotein I--SZ-2. 1987 Sci. Sin., Ser. B, Chem. Biol. Agric. Med. Earth Sci. pmid:3659897
Feuerstein G et al. Protective effect of a PAF-acether antagonist, BN 52021, in trichothecene toxicosis. 1987 Toxicol. Lett. pmid:3660430
Heinsohn C et al. The effect of bovine serum albumin on the synthesis of prostaglandin and incorporation of [3H]acetate into platelet-activating factor. 1987 Arch. Biochem. Biophys. pmid:3662526
Haroldsen PE et al. Quantitation of lyso-platelet activating factor molecular species from human neutrophils by mass spectrometry. 1987 J. Lipid Res. pmid:3104521
Teng CM et al. Antiplatelet effect of butylidenephthalide. 1987 Biochim. Biophys. Acta pmid:3109495
Földes-Filep E et al. Inhibition by BN 52021 (ginkgolide B) of the binding of [3H]-platelet-activating factor to human neutrophil granulocytes. 1987 Biochem. Biophys. Res. Commun. pmid:2825685
Kimura Y et al. Effects of baicalein on leukotriene biosynthesis and degranulation in human polymorphonuclear leukocytes. 1987 Biochim. Biophys. Acta pmid:2825795
Vargaftig BB and Braquet PG PAF-acether today--relevance for acute experimental anaphylaxis. 1987 Br. Med. Bull. pmid:2825900
Mathur RS et al. Current concepts in asthma. 1987 J Assoc Physicians India pmid:3320019
Whatley RE et al. Production of platelet-activating factor by endothelial cells. 1987 Semin. Thromb. Hemost. pmid:3321437
Kelton JG and Murphy WG Acute thrombocytopenia and thrombosis. Heparin-induced thrombocytopenia and thrombotic thrombocytopenic purpura. 1987 Ann. N. Y. Acad. Sci. pmid:3322132
Ho YS et al. Chemoattractant-induced activation of c-fos gene expression in human monocytes. 1987 J. Exp. Med. pmid:3108444
Kurachi M et al. Suppression of bronchial response to platelet activating factor following taurine administration. 1987 Adv. Exp. Med. Biol. pmid:3434419
Matsuno K et al. [Cytoplasm free calcium ions as a second messenger]. 1987 Rinsho Byori pmid:3437533
Kawamura Y et al. [A simple measurement of plasma platelet-activating factor (PAF) acetylhydrolase, normal level of activity, and distribution among lipoprotein fractions]. 1987 Rinsho Byori pmid:3437547
Kertscher HP and Ostermann G [Synthesis and platelet aggregating activity of structural analogs of platelet-activating factor with a heterocyclic head group]. 1987 Pharmazie pmid:3438334
Maudsley DJ and Morris AG Rapid intracellular calcium changes in U937 monocyte cell line: transient increases in response to platelet-activating factor and chemotactic peptide but not interferon-gamma or lipopolysaccharide. 1987 Immunology pmid:3110054
Lianos EA and Zanglis A Biosynthesis and metabolism of 1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine in rat glomerular mesangial cells. 1987 J. Biol. Chem. pmid:3110152
Bull HA and Machin SJ The haemostatic function of the vascular endothelial cell. 1987 Blut pmid:3111566
Touqui L et al. The role of Ca2+ in regulating the catabolism of PAF-acether (1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine) in rabbit platelets. 1987 Biochem. J. pmid:3109377
Moodley I and Stuttle A Evidence for a dual pathway in platelet activating factor-induced aggregation of rat polymorphonuclear leucocytes. 1987 Prostaglandins pmid:3035617
Codde JP et al. Effects of altered prostanoid and lyso-PAF synthesis by marine oil diets on blood pressure of salt loaded spontaneously hypertensive rats. 1987 Agents Actions Suppl. pmid:3481207